Not all individuals with CLL need therapy. Even with all latest improvements, the iwCLL still suggests watchful observation for patients with asymptomatic disorder.86 This suggestion relies on no less than two randomized trials evaluating observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).ddbola selalu